Abstract
Background Betel quid (BQ) chewing is a common habit and a means of social interaction among the northeastern peoples of Bangladesh. Though this habit integrating in their daily life without knowing its toxic effect. Areca nut, which is one of the main components of BQ and may responsible for this addiction. Here, we assess to see how BQ chewing habit influence hyperglycemia among diabetic patients with respect to their lifestyle.
Methodology Random blood sugar (RBS) test was evaluated from a total of 961 diabetic patients. Behavioral data associated with their daily lifestyle were collected from August 2018 to February 2019 from Sylhet Diabetic Hospital, Bangladesh. Student’s t-test, ANOVA and Fisher’s exact test were used to assess the RBS status between BQ chewer and non-chewer patients.
Results Higher RBS was found in BQ chewer patients than non-chewer (mean ± SEM, 263.3 ± 4.768 vs. 251.0 ± 5.915mg/dl). Interestingly, it is significantly higher in raw areca nut user than dry nut (mean ± SEM, 278.0 ± 8.790 vs. 252.1 ± 6.835 mg/dl) only from BQ chewer group, suggesting that the habit of chewing raw nut may contribute to more hyperglycemic effect among diabetic patients. BQ habit enhances higher RBS level among smoker, non-smoker and patient’s having walking habit. In addition, BQ habit significantly influence to have high RBS in patients with family history with diabetes. Lack of awareness being diabetes have also been observed significantly in BQ chewer patients, while a higher level of RBS was seen in BQ group, who work in different sectors with sitting activities.
Conclusions Diabetic patients who chew betel quid are more prone to keep higher hyperglycemic. Utmost attention should be taken to discourage the use of BQ for proper management of diabetes control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be available with few restrictions stipulated by Shahjalal University of Science and Technology (SUST), Sylhet, Bangladesh